Jazz Pharmaceuticals PLC (STU:J7Z)
€ 98.84 0.64 (0.65%) Market Cap: 6.13 Bil Enterprise Value: 9.78 Bil PE Ratio: 22.06 PB Ratio: 1.82 GF Score: 78/100

Jazz Pharmaceuticals PLC at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 05:20PM GMT
Release Date Price: €120 (+3.45%)
Brandon Richard Folkes
Cantor Fitzgerald & Co., Research Division - Analyst

Good afternoon, everyone, and thank you very much for joining us on Day 2 for the 2020 Cantor Fitzgerald Virtual Health Care Conference this year. I am Brandon Folkes, and I'm a biopharma analyst here at Cantor. Next up, we have a formal presentation from Jazz Pharmaceuticals. And joining me today from Jazz is CEO, Bruce Cozadd. Bruce, thank you very much for joining us today. Before I turn it over to you, I just want to let investors know who may be joining us. It's likely we're probably going to run short of time for Q&A. And what we've been doing with a lot of the Q&A., if you just e-mail that directly to me, I'll get that across to Bruce and the company, and they can get back to you. So Bruce, thank you very much for joining us. Please take it away.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Well, thank you, Brandon, for the opportunity to present today at your Global Healthcare Conference, and thank you all for joining us. I'm really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot